Non-tubal ectopic pregnancy treatment experiences of a tertiary care center
Yazarlar (7)
Yildiz Akdas Reis Etlik Zubeyde Hanım Matern & Womens Hlth Tea, Türkiye
Dr. Öğr. Üyesi Arife AKAY ACEMOĞLU Etlik Zubeyde Hanım Matern & Womens Hlth Tea, Türkiye
Dr. Öğr. Üyesi Merve Ozkan Etlik City Hosp, Türkiye
Seval Yilmaz Ergani
Etlik City Hosp, Türkiye
Dr. Öğr. Üyesi Sadullah Ozkan Etlik City Hosp, Türkiye
Tugba Kinay Etlik Zubeyde Hanım Matern & Womens Hlth Tea, Türkiye
Salim Erkaya
Bilkent City Hosp, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Archives of Gynecology and Obstetrics (Q2)
Dergi ISSN 0932-0067 Dergi Bilgileri (2024)
Dergi Tarandığı Indeksler SCI
Makale Dili Türkçe Basım Tarihi 01-2024
Kabul Tarihi 07-12-2023 Yayınlanma Tarihi 22-01-2024
Cilt / Sayı / Sayfa 310 / 2 / 1141–1149 DOI 10.1007/s00404-023-07338-5
Makale Linki https://link.springer.com/10.1007/s00404-023-07338-5
UAK Araştırma Alanları
Kadın Hastalıkları ve Doğum
Özet
Aim: To evaluate the incidence, the risk factors, and the treatment outcomes of Non-tubal ectopic pregnancies (NTEP) treated in a tertiary care center. Material and methods: A total of 110 NTEP cases treated between 2014 and 2019 were included in the retrospective study. The study cohort was divided into 6 groups according to the pregnancy localization: 87 cesarean scar pregnancies (CSPs), 7 ovarian pregnancies, 6 interstitial pregnancies, 4 rudimentary horn pregnancies, 4 abdominal pregnancies, and 2 cervical pregnancies. One woman rejected all treatment modalities. Demographic characteristics, treatment modalities, and outcomes of each group were evaluated. Results: In the study cohort, expectant management was performed in one (0.9%) woman. The methotrexate (MTX) treatment was administered in 29 (26.3%) women. Seventeen (15.4%) women underwent surgery, and 63 (57.2%) women underwent manual vacuum aspiration (MVA). A woman rejected all treatment modalities. Although 70.1% (n = 61) of CSPs were cured with MVA, 24.1% (n = 21) of them were treated with a single-dose MTX regimen in addition to MVA. The higher mean gestational sac size (33,9 ± 12,96 mm vs. 17,34 ± 9,87 mm), the higher mean gestational week (8,43 ± 1,16w vs. 6,66 ± 1,49w), the presence of fetal heartbeat (FHB) (90.5% vs. 26,2%) and the history of pelvic ınflammatory disease (PID) (38.1% vs. 6,6%) were found in the CSPs with MVA treatment failure (p < 0.05). Conclusion: The management of NTEPs should be individualized according to the clinical and ultrasonographic findings. The size of the ectopic pregnancy mass, the gestational week, the presence of FHB, and the PID history were the predictive factors for the failure of MVA in CSP cases.
Anahtar Kelimeler
"Non-Tubal" | "Ectopic Pregnancy" | "Cesarean Scar Pregnancy" | "Methotrexate" | "Manual vacuum aspiration" | "Surgery"
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Web of Science 3
Scopus 4
PubMed 3
Non-tubal ectopic pregnancy treatment experiences of a tertiary care center